Cargill introduces barley fibre for heart health

US agri-giant Cargill introduced a new barley ingredient, with high
levels of beta-glucan soluble fibre, at Health Ingredients Europe
last week, as part of its platform designed to target heart health.

Lee Knudsen, product manager at the group's health and food technologies unit, said the ingredient's high purity stood out against other available beta-glucans that usually only have around 50 per cent beta-glucans.

The ingredient has also been designed to improve on the formulation challenges previously seen with high viscosity beta-glucans.

Cargill​, which is aiming to build a strong portfolio of heart health products around its core plant sterols and soy protein ingredients, is currently waiting for the results of pre-clinical and clinical studies on the barley fibre to be completed this month and published next year.

It is also in the process of scaling up a new plant to produce the ingredient in the US, where it is already the largest malt maker.

Foods designed to tackle heart health are set to grow by 7.6 per cent to reach sales of £145 million in the UK alone by 2007, according to Datamonitor.

Related news

Related products

show more

Your Product Innovation Begins Here: Booth 4055

Your Product Innovation Begins Here: Booth 4055

Content provided by Effepharm Ltd | 22-Oct-2024 | Product Brochure

EffePharm will showcase innovative anti-aging solutions, featuring UthPeak™, world’s first self-GRAS approved NMNH, which boosts NAD+ levels by 10X. UthPeak™...

Sports Nutrition Formulations Re-imagined

Sports Nutrition Formulations Re-imagined

Content provided by Gencor | 30-Sep-2024 | White Paper

Gencor offers scientifically proven sports nutrition solutions intentionally designed for optimal performance and recovery for any level of athletic activity,...

Tackling Metabolic Health with HIMABERB® Berberine

Tackling Metabolic Health with HIMABERB® Berberine

Content provided by Pharma Base S.A. | 18-Sep-2024 | White Paper

Metabolic health is a prevalent and rapidly growing global challenge. In recent years, there has been mounting clinical evidence to support the use of...

Related suppliers

Follow us

Products

View more

Webinars